The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price. Immix (ticker: IMMX) is the third company this week to trade below its ...
网页链接The IPO market is set to close out 2021 with a thud after Immix Biopharma, a biotech, dropped nearly 27% below its offer price. Immix (ticker: IMMX) is the third company this week to trade below its ...
网页链接
精彩评论